Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aveanna Healthcare Holdings Inc. filings document the public-company disclosures of a home healthcare operator with pediatric and adult care services. Its 8-K reports cover operating and financial results, guidance updates, Regulation FD investor presentations, material-event disclosures, capital-structure matters, and material agreements tied to the company and its common stock.
Proxy and governance filings describe annual meeting matters, board composition, committee service, executive compensation arrangements, employment agreements, stock incentive plan matters, and stockholders agreement provisions, including transfer restrictions and ownership-guideline-related terms. The filing record also includes director transitions and governance disclosures connected to compensation, nominating and corporate governance, and clinical quality and compliance oversight.
Aveanna Healthcare Holdings Inc. files its annual report describing a large, diversified home care platform focused on medically complex, high‑cost patients treated at home. The company operates across three segments—Private Duty Services, Home Health & Hospice, and Medical Solutions—serving multiple age groups in 38 states.
Aveanna highlights scale advantages, dense local networks, and extensive technology investments in recruiting, scheduling, electronic medical records, and revenue cycle tools. It reports more than 1,500 distinct payers, substantial Medicaid and Medicare exposure, and emphasizes value‑based care, acquisitions (18 since 2017), and a strong compliance culture.
Aveanna Healthcare reported strong growth for the quarter and fiscal year ended January 3, 2026. Fourth quarter revenue was $662.5 million, up 27.4% from the prior year, with net income of $178.8 million versus $29.2 million. Adjusted EBITDA rose to $85.0 million, a 54.0% increase.
For 2025, revenue reached $2,433.2 million, up 20.2%, and the company swung to full-year net income of $225.0 million from a $10.9 million loss. Full-year Adjusted EBITDA grew to $320.9 million, up 74.8%. Management reaffirmed 2026 guidance for revenue of $2.54–$2.56 billion and Adjusted EBITDA of $318–$322 million.
Aveanna also agreed to acquire Family First Homecare for $175.5 million, expected to close in the second fiscal quarter of 2026, expanding its pediatric home care footprint. As of January 3, 2026, the company had cash of $193.3 million, free cash flow of $131.0 million for 2025, and total indebtedness of $1,486.7 million.
Aveanna Healthcare Holdings, Inc. director Samuel Altman has filed an initial Form 3 statement of beneficial ownership. The excerpt lists him as a director of the company and shows no reported buy, sell, or other share transactions in this filing data.
Aveanna Healthcare Holdings Inc. is expanding its pediatric home care network by agreeing to acquire Family First Holding, LLC for a cash purchase price of $175.5 million, subject to customary adjustments. Aveanna plans to fund the deal with cash on hand and existing short-term credit facility borrowings.
Family First Homecare is a multi-state pediatric home care provider with 27 locations across seven states, focused on skilled Private Duty Nursing. The transaction is expected to close in Aveanna’s second fiscal quarter of 2026, subject to Hart-Scott-Rodino clearance, customary closing conditions, and the absence of a material adverse effect.
Aveanna Healthcare Holdings Inc. reported that Robert M. Williams, Jr. has resigned from its Board of Directors effective February 27, 2026. He had served as a Class I director and was a member of the Nominating and Corporate Governance, Compensation, and Clinical Quality and Compliance Committees.
The company stated that Mr. Williams’ decision to resign was not due to any disagreement with Aveanna regarding its operations, policies, or practices. The filing is signed by Chief Executive Officer Jeff Shaner.
Aveanna Healthcare Holdings Inc. updated employment agreements for its President and CEO Jeff Shaner, CFO Matthew Buckhalter, and Chief Legal Officer Jerry Perchik through its Aveanna Healthcare, LLC subsidiary. The new contracts set minimum annual base salaries of $750,000 for Shaner, $500,000 for Buckhalter, and $450,000 for Perchik, with target annual bonuses equal to 100%, 75%, and 75% of salary, respectively, plus eligibility for discretionary equity awards under the 2021 Stock Incentive Plan.
If terminated without cause or resigning for good reason outside a change in control, Shaner is eligible for cash severance equal to 2x salary plus target bonus, while Buckhalter and Perchik receive 1x, along with pro‑rated bonuses, partial vesting of equity, and subsidized COBRA for up to 24 months for Shaner and 12 months for the others. During a defined change in control period, severance rises to 2.5x salary plus target bonus for Shaner and 2x for the others, full vesting of equity based on actual or target performance, and COBRA-related cash or subsidies for 30 months for Shaner and 24 months for the others. All severance requires a signed release and continued compliance with non‑competition, non‑solicitation, non‑disparagement, and confidentiality covenants.
Aveanna Healthcare Holdings Chief Executive Officer Jeff Shaner reported tax-related stock sales. Over February 17–19, 2026, he sold a total of 461,909 shares of common stock in open-market transactions at weighted average prices between about $7.06 and $7.97. According to the footnotes, these sales were automatically executed by the company’s stock plan administrator to cover his tax obligations arising from vested equity awards. After these sales, Shaner directly held 2,650,892 shares of Aveanna common stock.
Aveanna Healthcare Holdings, Inc. Chief Compliance Officer Patrick A. Cunningham reported automatic sales of common stock to cover taxes on vested equity awards. Over February 17–19, 2026, he sold a total of 49,160 shares in open-market transactions at weighted average prices ranging from $7.06 to $7.97 per share, as part of aggregate sales handled by the company’s stock plan administrator. Following these sales, he directly holds 337,755 shares of Aveanna common stock.
Aveanna Healthcare Holdings, Inc. Chief Financial Officer Matthew Buckhalter reported open-market sales of a total of 36,030 shares of common stock over three days. The sales occurred on February 17, 18, and 19, 2026 at weighted average prices of $7.6451, $7.3829, and $7.2082 per share, respectively.
According to the footnotes, these shares were automatically sold to satisfy the reporting person’s tax obligations arising from shares issued upon vesting of equity awards and were executed as part of aggregate sales by the company’s stock plan administrator. After these transactions, Buckhalter directly owns 529,243 shares of Aveanna common stock.
Aveanna Healthcare Holdings senior vice president and chief accounting officer Deborah Stewart reported open-market sales of 29,815 shares of common stock over three days. The shares were automatically sold by the company’s stock plan administrator to satisfy her tax obligations on recently vested equity awards, and she continues to hold over 300,000 shares directly.